rizoplus flydende middel
nordisk alkali - sprede-klæbemiddel - flydende middel - 1000 g/l sprede-klæbemiddel
prehevbri
vbi vaccines b.v. - hepatitis b overflade antigen - hepatitis b - vacciner - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.
foscarnet "tillomed" 24 mg/ml infusionsvæske, opløsning
tillomed pharma gmbh - foscarnetnatriumhexahydrat - infusionsvæske, opløsning - 24 mg/ml
treprostinil "tillomed" 10 mg/ml infusionsvæske, opløsning
tillomed pharma gmbh - treprostinil - infusionsvæske, opløsning - 10 mg/ml
treprostinil "tillomed" 1 mg/ml infusionsvæske, opløsning
tillomed pharma gmbh - treprostinil - infusionsvæske, opløsning - 1 mg/ml
treprostinil "tillomed" 2,5 mg/ml infusionsvæske, opløsning
tillomed pharma gmbh - treprostinil - infusionsvæske, opløsning - 2,5 mg/ml
treprostinil "tillomed" 5 mg/ml infusionsvæske, opløsning
tillomed pharma gmbh - treprostinil - infusionsvæske, opløsning - 5 mg/ml
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - alle andre terapeutiske produkter - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.